英文_Bernstein_美国生命科学工具与诊断_月度行业健康追踪（5月数据+会议要点）_22页_2mb
报告摘要
US Life Science Tools & Diagnostics Sector Health Tracker Summary
The report analyzes the health of the US Life Science Tools & Diagnostics sector based on qualitative commentary from May/June conferences and quantitative metrics. Qualitative sentiment is mixed, with optimism on NIH funding and the new administration but pessimism on biotech funding and pharma cautiousness. Quantitative data shows most metrics negative year-over-year, though clinical trial starts and pharma R&D spend were exceptions. Overall, the sector faces headwinds but shows signs of improvement in specific areas.
展开完整摘要
试读结束，高清完整版pdf/doc/ppt,请点下载
